Renaissance Group LLC lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 4,375.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 265,044 shares of the company's stock after acquiring an additional 259,122 shares during the period. Renaissance Group LLC owned approximately 0.11% of Cardinal Health worth $31,347,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Rothschild Investment LLC increased its holdings in Cardinal Health by 10.1% during the 4th quarter. Rothschild Investment LLC now owns 858 shares of the company's stock worth $101,000 after purchasing an additional 79 shares in the last quarter. Private Trust Co. NA grew its holdings in shares of Cardinal Health by 11.0% during the fourth quarter. Private Trust Co. NA now owns 930 shares of the company's stock worth $110,000 after buying an additional 92 shares in the last quarter. Checchi Capital Advisers LLC raised its position in Cardinal Health by 2.7% in the 4th quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock valued at $411,000 after buying an additional 93 shares during the last quarter. TIAA Trust National Association lifted its stake in Cardinal Health by 4.5% in the 4th quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock valued at $258,000 after acquiring an additional 94 shares in the last quarter. Finally, MWA Asset Management boosted its position in Cardinal Health by 2.9% during the 4th quarter. MWA Asset Management now owns 3,324 shares of the company's stock worth $393,000 after acquiring an additional 95 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.
Cardinal Health Trading Up 2.1 %
Shares of NYSE:CAH traded up $2.77 on Friday, hitting $131.65. The company had a trading volume of 2,168,139 shares, compared to its average volume of 2,182,169. The stock has a market cap of $31.80 billion, a price-to-earnings ratio of 24.56, a P/E/G ratio of 1.49 and a beta of 0.61. The stock has a 50 day moving average price of $129.33 and a 200 day moving average price of $122.48. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $139.50.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.54%. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.
Analysts Set New Price Targets
CAH has been the topic of a number of research reports. Evercore ISI raised shares of Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price objective on the stock in a research report on Tuesday, January 7th. Jefferies Financial Group upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and increased their price objective for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Wells Fargo & Company lifted their target price on Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 4th. Morgan Stanley increased their price target on Cardinal Health from $136.00 to $142.00 and gave the company an "overweight" rating in a research report on Friday, January 31st. Finally, Argus set a $148.00 price target on Cardinal Health in a research report on Tuesday, February 4th. Four analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, Cardinal Health has a consensus rating of "Moderate Buy" and an average target price of $140.86.
Check Out Our Latest Report on CAH
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
